An anonymous director reports

NUMINUS TO HOST Q1 FISCAL 2024 RESULTS CONFERENCE CALL ON JANUARY 15, 2024

Numinus Wellness Inc. will release its financial results for the quarter ended Nov. 30, 2023, after the market close on Tuesday, Jan. 15, 2024.

Interested parties are invited to participate in the company's Q1 2024 results conference call and webcast occurring on the same day at 5:30 p.m. Eastern Time (2:30 p.m. Pacific Time). During the call, Numinus executives will review the company's performance and recent initiatives.

A question-and-answer session will follow management's prepared remarks. At this time, the operator will provide instructions for qualified equity analysts to submit questions. Investors are invited to submit questions by e-mail to invest@numinus.com. A selection of questions will be answered by management on the call and all e-mailed questions will be responded to by e-mail.

To listen to the live webcast, please register on-line.

The webcast will also be archived on the events and presentations page of Numinus's investor relations website.

To participate in the live conference call, please use the following dial-in information:

• 1-888-330-3632 (toll-free in North America);
• 1-646-960-0837 (international).

Ask to participate in Numinus's Q1 2024 results call.

To avoid any delays in joining the call, please dial in at least five minutes prior to the call start time. If prompted, please provide conference passcode 3547386.

A replay of the conference call can also be accessed after 8:30 p.m. Eastern Time (5:30 p.m. Pacific Time) on Jan. 15, 2024, at 1-800-770-2030 or 1-647-362-9199 (using passcode 3547386). The replay will be available until Jan. 29, 2024.

About Numinus Wellness Inc.

Numinus Wellness helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model -- including psychedelic research and clinic care -- is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. Numinus is leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.